Developing new drugs and vaccines for cancer treatment
Official title: Contract Orientation and Kickoff Meeting
Funded at Weill Medical Coll of Cornell Univ · NIH-11020341 · Data updated 2026-11-12
This study is working on a new program to help develop better drugs and vaccines for cancer, so patients can have access to more effective treatments in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | January 25, 2024 |
| Project end | January 24, 2029 |
| Funding year | 2024 |
| Award (this year) | $3,500 |
| NIH project number | 75N91024D00006-0-759102400001-1 |
| Project ID | NIH-11020341 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with various types of cancer who are seeking new treatment options.
✕Less likely to help
Patients with non-malignant conditions or those not currently diagnosed with cancer may not receive any benefit from this research.
What this research studies
This research focuses on creating a structured program for the development of drugs and vaccines aimed at treating cancer. It involves a systematic approach from the initial discovery phase through to clinical application, ensuring that new therapies are rigorously tested for efficacy. Patients may benefit from advancements in cancer treatment as new therapies are developed and evaluated through this program.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective cancer treatments and vaccines.
How similar studies have gone: Previous research in preclinical drug development has shown promise in advancing cancer therapies, indicating that this approach has potential for success.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Lipkin, Steven M — Weill Medical Coll of Cornell Univ
- Study coordinator: Lipkin, Steven M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.